Antithrombotic treatment for atrial fibrillation. Patients must be told full details of risks of treatment
- PMID: 10480840
- PMCID: PMC1116556
- DOI: 10.1136/bmj.319.7211.708
Antithrombotic treatment for atrial fibrillation. Patients must be told full details of risks of treatment
Comment on
-
Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.BMJ. 1999 May 15;318(7194):1324-7. doi: 10.1136/bmj.318.7194.1324. BMJ. 1999. PMID: 10323820 Free PMC article.
References
-
- Caro JJ, Groome PA, Flegel KM. Atrial fibrillation and anticoagulants: from randomised trials to practice. Lancet. 1993;341:1381–1384. - PubMed
-
- Man-Son-Hing M, Laupacis A, O’Connor A, Wells G, Lemelin J, Wood W, et al. Warfarin for atrial fibrillation. The patient’s perspective. Arch Intern Med. 1996;156:1841–1848. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical